Novavax coronavirus vaccine induces immune response in early study, shares jump

This post was originally published on this site

(Reuters) – Novavax Inc said on Tuesday its experimental COVID-19 vaccine produced high levels of antibodies against the novel coronavirus, according to initial data from a small, early-stage clinical trial, sending the company’s shares up 10%. The company …

Click here to read full article